277 related articles for article (PubMed ID: 22002814)
1. Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists.
Chandra M; Levitt J; Pensabene CA
Acta Derm Venereol; 2012 May; 92(3):232-5. PubMed ID: 22002814
[TBL] [Abstract][Full Text] [Related]
2. Hydroquinone: myths and reality.
Searle T; Al-Niaimi F; Ali FR
Clin Exp Dermatol; 2021 Jun; 46(4):636-640. PubMed ID: 33159818
[TBL] [Abstract][Full Text] [Related]
3. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
[TBL] [Abstract][Full Text] [Related]
4. Acne in ethnic skin: special considerations for therapy.
Callender VD
Dermatol Ther; 2004; 17(2):184-95. PubMed ID: 15113286
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acne vulgaris using blue light photodynamic therapy in an African-American patient.
Terrell S; Aires D; Schweiger ES
J Drugs Dermatol; 2009 Jul; 8(7):669-71. PubMed ID: 19588644
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study.
Kircik LH
J Drugs Dermatol; 2011 Jun; 10(6):586-90. PubMed ID: 21637899
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study.
Kalasho BD; Minokadeh A; Zhang-Nunes S; Zoumalan RA; Shemirani NL; Waldman AR; Pletzer V; Zoumalan CI
J Cosmet Sci; 2020; 71(5):263-290. PubMed ID: 33022197
[TBL] [Abstract][Full Text] [Related]
8. Considerations for treating acne in ethnic skin.
Callender VD
Cutis; 2005 Aug; 76(2 Suppl):19-23. PubMed ID: 16164153
[TBL] [Abstract][Full Text] [Related]
9. The safety of hydroquinone.
Nordlund JJ; Grimes PE; Ortonne JP
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):781-7. PubMed ID: 16898897
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
[TBL] [Abstract][Full Text] [Related]
11. A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids).
Mathe N; Balogun M; Yoo J
J Cosmet Dermatol; 2021 Jan; 20(1):204-206. PubMed ID: 32997864
[TBL] [Abstract][Full Text] [Related]
12. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation.
Abad-Casintahan F; Chow SK; Goh CL; Kubba R; Hayashi N; Noppakun N; See J; Suh DH; Xiang LH; Kang S;
J Dermatol; 2016 Jul; 43(7):826-8. PubMed ID: 26813513
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
[TBL] [Abstract][Full Text] [Related]
14. Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
Callender VD; Baldwin H; Cook-Bolden FE; Alexis AF; Stein Gold L; Guenin E
Am J Clin Dermatol; 2022 Jan; 23(1):69-81. PubMed ID: 34751927
[TBL] [Abstract][Full Text] [Related]
15. Chemical and instrumental approaches to treat hyperpigmentation.
Briganti S; Camera E; Picardo M
Pigment Cell Res; 2003 Apr; 16(2):101-10. PubMed ID: 12622786
[TBL] [Abstract][Full Text] [Related]
16. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone.
Kakita LS; Lowe NJ
Clin Ther; 1998; 20(5):960-70. PubMed ID: 9829447
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
[TBL] [Abstract][Full Text] [Related]
18. [Toxicological aspects and health risks associated with hydroquinone in skin bleaching formula].
Kooyers TJ; Westerhof W
Ned Tijdschr Geneeskd; 2004 Apr; 148(16):768-71. PubMed ID: 15129564
[TBL] [Abstract][Full Text] [Related]
19. Nail staining from hydroquinone cream.
Ozluer SM; Muir J
Australas J Dermatol; 2000 Nov; 41(4):255-6. PubMed ID: 11105373
[TBL] [Abstract][Full Text] [Related]
20. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts.
Goh CL; Abad-Casintahan F; Chow SK; Kubba R; Miyachi Y; Noppakun N; See J; Suh DH; Xiang LF; Kang S;
J Dermatol; 2014 Dec; 41(12):1106-8. PubMed ID: 25327447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
